Target Name: PGK2
NCBI ID: G5232
Review Report on PGK2 Target / Biomarker Content of Review Report on PGK2 Target / Biomarker
PGK2
Other Name(s): PGKPS | PGK-2 | epididymis secretory protein Li 272 | PGKB | phosphoglycerate kinase, testis specific | OTTHUMP00000016591 | dJ417L20.2 | testicular tissue protein Li 139 | phosphoglycerate kinase 2 | Phosphoglycerate kinase autosomal pseudogene | Phosphoglycerate kinase, testis specific | Phosphoglycerate kinase 1, pseudogene 2 | Phosphoglycerate kinase 2 | phosphoglycerate kinase autosomal pseudogene | HEL-S-272 | PGK2_HUMAN

PGK2: Key Regulator of CAMP/PKA and Stress Response

PGK2 (polyglandular potassium channel) is a protein that is expressed in various tissues and cells in the body. It is a key regulator of the intracellular signaling pathway known as the cAMP/PKA pathway, which is involved in a wide range of physiological processes including cell signaling, protein synthesis, and stress response. PGK2 has also been shown to play a role in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. As a result, PGK2 has become a focus of interest in the scientific community and a potential drug target.

The cAMP/PKA pathway is a critical signaling pathway that is involved in the regulation of many cellular processes in the body. It is a two-component pathway that is activated by the binding of the second messenger molecule cAMP (cyclophosphamide). Once activated, the pathway results in the production of a third molecule, PKA (cAMP-protein kinase), which in turn can cause a variety of cellular responses, including protein synthesis, gene expression, and intracellular signaling. PGK2 is a key regulator of this pathway and is involved in the regulation of its activity.

PGK2 is a protein that is expressed in various tissues and cells in the body, including muscle, heart, kidney, and brain. It is a member of the PKA subfamily of the protein kinase family and is characterized by its catalytic active site, which is responsible for the catalytic activity of the protein. PGK2 has a unique structure that is composed of a catalytic active site, a regulatory domain, and a carboxylic acid tail. The catalytic active site is the site of the protein's catalytic activity and is responsible for the The regulatory domain is responsible for regulating the activity of the protein and is involved in the regulation of the cAMP/PKA pathway. The carboxylic acid tail is the tail of the protein that is responsible for its stability and for interacting with other proteins.

PGK2 has been shown to play a role in the regulation of various cellular processes in the body. For example, studies have shown that PGK2 is involved in the regulation of protein synthesis and that it can modulate the activity of the ribosome, a protein that is responsible for the production of proteins from RNA. Additionally, PGK2 has been shown to be involved in the regulation of stress response, as it has been shown to play a role in the regulation of the expression of genes involved in stress response.

PGK2 has also been shown to be involved in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. For example, studies have shown that PGK2 is involved in the regulation of the growth and survival of cancer cells and that it can inhibit the activity of a protein called NF-kappa-B, which is involved in the regulation of cancer cell growth and survival. Additionally, PGK2 has been shown to be involved in the regulation of the development and progression of neurodegenerative diseases, as it has has been shown to play a role in the regulation of the expression of genes involved in neurodegenerative diseases.

As a result of its involvement in the cAMP/PKA pathway and its role in the regulation of various cellular processes in the body, PGK2 has become a focus of interest in the scientific community. Researchers are actively searching for new ways to target PGK2 as a potential drug or biomarker. There is a growing interest in developing small molecules that can inhibit the activity of PGK2 and in using these small molecules as therapeutic agents for a variety of diseases. Additionally, there is a growing interest in developing new techniques for the detection and quantification of PGK2, as this protein is expressed in a variety of tissues and cells in the body and its levels can vary depending on the specific cell type and context.

In conclusion, PGK2 is a protein that is involved in the regulation of

Protein Name: Phosphoglycerate Kinase 2

Functions: Essential for sperm motility and male fertility (PubMed:26677959). Not required for the completion of spermatogenesis (By similarity)

The "PGK2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PGK2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

PGLS | PGLYRP1 | PGLYRP2 | PGLYRP3 | PGLYRP4 | PGM1 | PGM2 | PGM2L1 | PGM3 | PGM5 | PGM5-AS1 | PGM5P2 | PGM5P4 | PGM5P4-AS1 | PGP | PGPEP1 | PGPEP1L | PGR | PGR-AS1 | PGRMC1 | PGRMC2 | PGS1 | PHACTR1 | PHACTR2 | PHACTR3 | PHACTR3-AS1 | PHACTR4 | PHAF1 | PHAX | PHB1 | PHB1P1 | PHB1P19 | PHB1P3 | PHB1P8 | PHB1P9 | PHB2 | PHC1 | PHC1P1 | PHC2 | PHC2-AS1 | PHC3 | Phenylalanyl-tRNA synthetase | PHETA1 | PHETA2 | PHEX | PHEX-AS1 | PHF1 | PHF10 | PHF11 | PHF12 | PHF13 | PHF14 | PHF19 | PHF2 | PHF2-ARID5B complex | PHF20 | PHF20L1 | PHF21A | PHF21B | PHF23 | PHF24 | PHF2P1 | PHF2P2 | PHF3 | PHF5A | PHF6 | PHF7 | PHF8 | PHGDH | PHGR1 | PHIP | PHKA1 | PHKA1-AS1 | PHKA2 | PHKA2-AS1 | PHKB | PHKG1 | PHKG2 | PHLDA1 | PHLDA2 | PHLDA3 | PHLDB1 | PHLDB2 | PHLDB3 | PHLPP1 | PHLPP2 | Phosphatidylinositol 3-kinase (PI3K) | Phosphatidylinositol 3-kinase complex (PIK3C3, PIK3R4) | Phosphatidylinositol 4-Kinase (PI4K) | Phosphatidylinositol 4-Kinase beta (PI4K-beta) | Phosphatidylinositol 4-phosphate 5-kinase | Phosphatidylinositol N-acetylglucosaminyltransferase | Phosphatidylinositol-5-phosphate 4-kinase | PHOSPHO1 | PHOSPHO2 | PHOSPHO2-KLHL23 | Phosphodiesterase | Phosphodiesterase 1 (PDE1) | Phosphodiesterase 6 (PDE6) | Phosphodiesterase 8 (nons